Xbrane Biopharma AB (XBRANE) — Cash Flow Reinvestment Rate
Xbrane Biopharma AB (XBRANE) has a Cash Flow Reinvestment Rate of 0.37x as of December 2024, reinvesting Skr34.60 Million (capex Skr17.30 Million plus investments Skr-17.30 Million) from operating cash flow of Skr93.91 Million. See free cash flow generation of Xbrane Biopharma AB to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xbrane Biopharma AB Cash Flow Reinvestment Rate (2018–2018)
Historical reinvestment intensity for Xbrane Biopharma AB across 1 annual periods. For the full cash flow conversion analysis, see Xbrane Biopharma AB (XBRANE) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Xbrane Biopharma AB (2018–2018)
Year-by-year capital reinvestment analysis for Xbrane Biopharma AB. See XBRANE financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.07x | Skr3.20 Million | Skr46.71 Million | Skr1.60 Million | — |